Third-party Access to Documents of the EU Medicines Agency (cepInput)

The CJEU sets a high bar for a refusal of access. In doing so, it judges in favour of the greatest possible transparency and thus supports general efforts to achieve greater legitimacy of European decision-making processes. It acknowledges the risk of misuse of the data disclosed but does not take the appropriate action. With its ruling, the CJEU has established a disproportionate "duty of disclosure" for marketing authorisation holders.